Brought to you by 
Series A round brings $33mm to smoking cessation company Chrono Therapeutics
11 Nov 2021
Executive Summary
Canaan Partners and 5AM Ventures led a $33mm Series A financing for transdermal drug/device company Chrono Therapeutics Inc. Fountain Healthcare Partners, Mayo Clinic, GE Ventures, and 26 undisclosed investors participated. Executives from Canaan Partners, 5AM Ventures, and Fountain joined Chrono’s board.
Deal Industry
- Medical Devices
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
- Transdermal
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series A round brings $33mm to smoking cessation company Chrono Therapeutics
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice